The course will provide a broad overview of key topics in biostatistics that are frequently at the forefront of litigation involving drugs and medical devices. The course will include a review of basic concepts including relative risks, odds ratios, statistical significance and power, comparing proportions, survival analysis, Bayesian analysis, metanalysis, and common issues in trial clinical conduct. The course will also touch on how these concepts figure into judicial opinions. Participants will learn to identify common red flags and pit falls in statistical analysis, develop tools to more effectively conduct discovery and interface with experts, and develop a sense for how courts view and understand these issues.
            Join Steve Herman on December 8, 2025, for "Maintaining Ethical Standards: Essential Strategies for ...
            This program will cover the sources from which practitioners can gather documents, witnesses, and ot...
            Session 9 of 10 - Mr. Kornblum, a highly experienced trial and litigation lawyer for over 50 years, ...
            Explore the transformative potential of generative AI in modern litigation. “Generative AI for...
            Leaving federal government employment for the private or nonprofit sector raises important ethics is...
            The GENIUS Act — signed into law on July 18, 2025 — marks the first comprehensive U.S. l...
            "I think he drinks too much - but he's my boss!" “She's the firm's rainmaker, but something i...
            In today’s fast-evolving digital landscape, data privacy is no longer just a compliance checkb...
            Clear, confident communication is one of the most powerful tools a lawyer can have, yet it’s o...
            In this presentation, Vanessa Terzian uses examples from actual client documents to demonstrate comm...